Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Follow-Up of Patients With Mitochondrial Carbonic Anhydrase VA Deficiency. A Case Report and Literature Review.

JIMD reports·2026
Same author

Burst-Suppression EEG in Early Infantile Developmental and Epileptic Encephalopathies: Phenotype, Genotype, and Outcome.

Neurology·2026
Same author

Climate change and Medicaid: leveraging health policy to support environmental protections for children.

Pediatric research·2026
Same author

Development and validation of a clinical severity score for long-chain fatty acid oxidation disorders using Real-World-Evidence from Canada.

Molecular genetics and metabolism·2026
Same author

An In Vitro Study Comparing Marginal Leakage of Resin Composite Restorations on Selectively Excavated Caries Lesions and Silver Diammine Fluoride.

Pediatric dentistry·2026
Same author

Advances in Predicting Postoperative Atrial Fibrillation: A Narrative Review of the Current Literature.

Cardiology in review·2026

Related Experiment Video

Updated: May 12, 2026

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

10.5K

Pediatric Status Dystonicus: A Single-Center 10-Year Retrospective Review.

Dakota J S J Peacock1, Keshvi Vithlani2,3, Grace A Clarke3,4

  • 1Division of Neurology, Department of Pediatrics, BC Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.

Movement Disorders Clinical Practice
|August 8, 2025
PubMed
Summary

Status dystonicus is a severe, life-threatening movement disorder emergency in children. This study highlights common triggers like infection and pain, emphasizing the need for standardized treatment guidelines to improve outcomes.

Keywords:
dystoniapediatricsretrospective seriesstatus dystonicus

More Related Videos

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
10:41

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

7.5K
Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

2.8K

Related Experiment Videos

Last Updated: May 12, 2026

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

10.5K
Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
10:41

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

7.5K
Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

2.8K

Area of Science:

  • Pediatric Neurology
  • Intensive Care Medicine
  • Movement Disorders

Background:

  • Status dystonicus is a critical medical emergency characterized by severe, generalized dystonia.
  • The condition's heterogeneous nature, including its causes and outcomes, complicates standardized management.
  • There is a need to better understand the characteristics and care of pediatric patients experiencing status dystonicus.

Purpose of the Study:

  • To characterize the demographics of pediatric patients with status dystonicus admitted to a pediatric intensive care unit (PICU).
  • To analyze management patterns and clinical outcomes for children experiencing status dystonicus.
  • To identify common triggers and treatment approaches for status dystonicus in a tertiary care setting.

Main Methods:

  • Retrospective review of clinical records at a tertiary children's hospital PICU from 2014 to 2024.
  • Inclusion criteria: patients aged >30 days with dystonia severity grade 3-5, or worsening dystonia.
  • Data collection included demographics, etiology, triggers, medications, PICU stay duration, and mortality.

Main Results:

  • Forty-one admissions from 19 unique pediatric patients were analyzed; mean age was 7.6 years, with 53% females.
  • Genetic etiology was common (42%), and infection (56%) or pain (15%) frequently triggered admissions.
  • Patients received multiple anti-dystonia medications; median PICU stay was 7 days, with a 4.9% mortality rate.

Conclusions:

  • Status dystonicus is a life-threatening pediatric emergency often precipitated by infection or pain.
  • The study underscores significant morbidity and mortality associated with status dystonicus.
  • Multidisciplinary teams should consider developing standardized treatment guidelines for managing these complex pediatric cases.